Summary
76 / 100 · Bulios Score
What speaks for it
- Revenue grew by 13% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
What to watch
- Analysts expect revenue to fall by 42% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 12.8 EUR for 1 EUR of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 21% a year over 5 years. Over the last 3 years it grew by 13% a year. For the next fiscal year analysts expect revenue to fall by 42%. Earnings per share grew by 10% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 EUR of revenue goes
- Cost of sales 47 EUR
- Sales and administration 33 EUR
- Taxes and other 4.4 EUR
- Net profit 15 EUR
Net profit, industry median (Banks - Regional) 21 EUR
Out of every 100 EUR of revenue, 15 EUR is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 4.38%
- Paid out of profit
- 56%
- Raised in a row
- 1 year
You receive $5.91 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 1
- Sell 0
No analyst has published a price target.
0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.